TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
SGMT

Sagimet Biosciences Inc. Series A

Healthcare · Biotechnology

8.80$ -3.0% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SGMT
Line item 2019 2020 2021 2022 2023 2024 2025
– +517.9% -14.4% -44.0% +192.8% +65.7% -27.3%
– +535.6% -14.7% -44.1% +194.7% +58.1% -23.8%
– +572.8% -17.4% -99.7% +47,456.3% +0.9% -53.8%
– +572.8% -17.4% -43.0% +193.4% +59.4% -25.2%
– -39.0% – – – – –
– +50.1% +6.1% +1.2% -97.4% -21.2% +14.5%
– -8.0% +27.7% +116.4% +7.1% -21.2% +14.5%
– +11.5% -14.5% +7.3% -51.1% +20.0% +0.0%
– -57.2% +48.3% +47.8% -83.5% +666.1% -8.1%
– – – – – +71.1% -28.5%
– – – – – – –
– +0.0% +0.0% +0.0% -17.9% +72.3% +3.2%

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?